Gastroparesis also known as delayed gastric emptying, is a disorder that stops or slows the movement of food through the digestive tract. Normally, the vagus nerve controls the stomach muscles, which are responsible for the movement of food in the stomach. These muscles contract to break up the food and lead to its movement through the gastrointestinal tract. Gastroparesis can be caused due to the damage of vagus nerve by illness or injury. The disease does not have complete remission; however, proper medications along with the changes in diet can provide relief.
Technavio’s analysts forecast the global gastroparesis drugs market to grow at a CAGR of 3.54% during the period 2017-2021.
Covered in this report The report covers the present scenario and the growth prospects of the global gastroparesis drugs market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography: • Americas • APAC • EMEA
Technavio's report, Global Gastroparesis Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors • Cadila Pharmaceuticals • GlaxoSmithKline • Johnson & Johnson • Valeant
Market driver • Rising cases of diabetes fueling the prevalence of diabetic gastroparesis. • For a full, detailed list, view our report
Market challenge • Difficulty in diagnosis is hampering the medication process. • For a full, detailed list, view our report
Market trend • Introduction of novel ways for the treatment of gastroparesis symptoms. • For a full, detailed list, view our report
Key questions answered in this report • What will the market size be in 2021 and what will the growth rate be? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space? • What are the market opportunities and threats faced by the key vendors? • What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Methodology Research methodology is based on extensive primary and secondary research. Primary research includes in-depth interviews with industry experts, vendors, resellers and customers. Secondary research includes Technavio Platform, industry publications, company reports, news articles, analyst reports, trade associations and the data published by Government agencies.
Our reports have been used by over 10K customers, including:
Gestational Diabetes Disease - Global Clinical Trials Review, H2, 2020 Summary clinical trial report, “Gestational Diabetes Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Gestational Diabetes Clinical trials scenario.This report provides top line data relating to the clinical...
The global regenerative medicine market is projected to reach USD 17.9 billion by 2025 from USD 8.5 billion in 2020, at a CAGR of 15.9% during the forecast period. Market growth is driven by the rising prevalence of chronic diseases, genetic disorders, and cancer; rising investments in regenerative medicine research; and the growing pipeline...
Systemic Lupus Erythematosus Global Clinical Trials Review, H2, 2020 Summary clinical trial report, “Systemic Lupus Erythematosus Global Clinical Trials Review, H2, 2020" provides an overview of Systemic Lupus Erythematosus Clinical trials scenario.This report provides top line data relating to the...
Islet Amyloid Polypeptide - Pipeline Review, H2 2020 Summary Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) - Islet amyloid polypeptide (IAPP) or Amylin is a peptide hormone. This hormone is released from pancreatic beta cells following food...